Publications

Found 1 results
Filters: Author is D. Derin  [Clear All Filters]
2010
O. Bitisik, Saip, P., Saglam, S., Derin, D., and Dalay, N., Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer, vol. 9, pp. 97-106, 2010.
Bae JW, Choi KH, Kim HG and Park SH (2000). The detection of circulating breast cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. J. Korean Med. Sci. 15: 194-198. PMid:10803697 PMCid:3054626   Ballestrero A, Garuti A, Bertolotto M, Rocco I, et al. (2005). Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br. J. Cancer 92: 1948-1952. http://dx.doi.org/10.1038/sj.bjc.6602563 PMid:15841077 PMCid:2361769   Bieche I, Girault I, Sabourin JC, Tozlu S, et al. (2003). Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas. Br. J. Cancer 88: 863-870. http://dx.doi.org/10.1038/sj.bjc.6600812 PMid:12644823 PMCid:2377080   Boltze C (2005). Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol. Res. Pract. 200: 783-790. http://dx.doi.org/10.1016/j.prp.2004.10.004 PMid:15792121   Bossolasco P, Ricci C, Farina G, Soligo D, et al. (2002). Detection of micrometastatic cells in breast cancer by RT-PCR for the mammaglobin gene. Cancer Detect. Prev. 26: 60-63. http://dx.doi.org/10.1016/S0361-090X(02)00009-0   Bostick PJ, Chatterjee S, Chi DD, Huynh KT, et al. (1998). Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol. 16: 2632-2640. PMid:9704713   Corradini P, Voena C, Astolfi M, Delloro S, et al. (2001). Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Ann. Oncol. 12: 1693-1698. http://dx.doi.org/10.1023/A:1013573108945 PMid:11843246   Denk AE, Bettstetter M, Wild PJ, Hoek K, et al. (2007). Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res. 20: 112-119. http://dx.doi.org/10.1111/j.1600-0749.2007.00363.x PMid:17371437   Fabisiewicz A, Kulik J, Kober P, Brewczynska E, et al. (2004). Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. Acta Biochim. Pol. 51: 747-755. PMid:15448736   Gonzalez-Mancha R, Galan JJ, Crespo C, Iglesias PL, et al. (2008). Analysis of the ERalpha germline PvuII marker in breast cancer risk. Med. Sci. Monit. 14: CR136-CR143. PMid:18301357   Khalkhali-Ellis Z and Hendrix MJ (2003). Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am. J. Pathol. 162: 1411-1417. http://dx.doi.org/10.1016/S0002-9440(10)64274-5   Khalkhali-Ellis Z, Christian AL, Kirschmann DA, Edwards EM, et al. (2004). Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen. Clin. Cancer Res. 10: 449-454. http://dx.doi.org/10.1158/1078-0432.CCR-1002-03 PMid:14760064   Klasa-Mazurkiewicz D, Narkiewicz J, Milczek T, Lipinska B, et al. (2009). Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. Gynecol. Oncol. 113: 91-98. http://dx.doi.org/10.1016/j.ygyno.2008.12.038 PMid:19193429   Krismann M, Todt B, Schroder J, Gareis D, et al. (1995). Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol. 13: 2769-2775. PMid:7595737   Leygue E, Snell L, Dotzlaw H, Hole K, et al. (1999). Mammaglobin, a potential marker of breast cancer nodal metastasis. J. Pathol. 189: 28-33. http://dx.doi.org/10.1002/(SICI)1096-9896(199909)189:1<28::AID-PATH389>3.0.CO;2-H   Luppi M, Morselli M, Bandieri E, Federico M, et al. (1996). Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann. Oncol. 7: 619-624. http://dx.doi.org/10.1093/oxfordjournals.annonc.a010680 PMid:8879377   Marioni G, Giacomelli L, D'Alessandro E, Marchese-Ragona R, et al. (2008). Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect? Am. J. Otolaryngol. 29: 156-162. http://dx.doi.org/10.1016/j.amjoto.2007.04.010 PMid:18439947   Marioni G, Koussis H, Gaio E, Giacomelli L, et al. (2009). MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence. Acta Otolaryngol. 129: 786-792. http://dx.doi.org/10.1080/00016480802412789 PMid:18819022   Marques AR, Teixeira E, Diamond J, Correia H, et al. (2009). Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence. Breast Cancer Res. Treat. 114: 223-232. http://dx.doi.org/10.1007/s10549-008-0002-9 PMid:18409061   Mercatali L, Valenti V, Calistri D, Calpona S, et al. (2006). RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients. Ann. Oncol. 17: 424-428. http://dx.doi.org/10.1093/annonc/mdj109 PMid:16357022   Min CJ, Tafra L and Verbanac KM (1998). Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res. 58: 4581-4584. PMid:9788605   Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, et al. (2006). Detection of mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin. Biochem. 39: 879-887. http://dx.doi.org/10.1016/j.clinbiochem.2006.06.009 PMid:16925986   Potemski P, Kusinska R, Pasz-Walczak G, Piekarski JH, et al. (2009). Prognostic relevance of cyclin E expression in operable breast cancer. Med. Sci. Monit. 15: MT34-MT40. PMid:19179977   Raj GV, Moreno JG and Gomella LG (1998). Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82: 1419-1442. http://dx.doi.org/10.1002/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4   Sabbatini R, Federico M, Morselli M, Depenni R, et al. (2000). Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J. Clin. Oncol. 18: 1914-1920. PMid:10784632   Secord AA, Lee PS, Darcy KM, Havrilesky LJ, et al. (2006). Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group Study. Gynecol. Oncol. 101: 390-397. http://dx.doi.org/10.1016/j.ygyno.2006.02.014 PMid:16551475   Sheng S, Carey J, Seftor EA, Dias L, et al. (1996). Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA 93: 11669-11674. http://dx.doi.org/10.1073/pnas.93.21.11669 PMid:8876194 PMCid:38116   Shi HY, Zhang W, Liang R, Kittrell F, et al. (2003). Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol. Histopathol. 18: 201-206. PMid:12507299   Silva AL, Diamond J, Silva MR and Passos-Coelho JL (2001). Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues. Breast Cancer Res. Treat. 66: 59-66. http://dx.doi.org/10.1023/A:1010628802290 PMid:11368411   Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, et al. (2003). Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Anticancer Res. 23: 1883-1890. PMid:12820473   Stojadinovic A, Hooke JA, Shriver CD, Nissan A, et al. (2007). HYOU1/Orp150 expression in breast cancer. Med. Sci. Monit. 13: BR231-BR239. PMid:17968289   Suchy B, Austrup F, Driesel G, Eder C, et al. (2000). Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett. 158: 171-178. http://dx.doi.org/10.1016/S0304-3835(00)00520-6   Surowiak P, Materna V, Drag-Zalesinska M, Wojnar A, et al. (2006). Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates. Int. J. Gynecol. Pathol. 25: 131-139. http://dx.doi.org/10.1097/01.pgp.0000183050.30212.2f PMid:16633061   Wang JY, Wu CH, Lu CY, Hsieh JS, et al. (2006). Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J. Surg. 30: 1007-1013. http://dx.doi.org/10.1007/s00268-005-0485-z PMid:16736329   Watson MA and Fleming TP (1996). Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 56: 860-865. PMid:8631025   Yoshihisa U, Yasuyo O, Yoshiatsu S and Hiroki Y (2002). Expression of maspin predicts poor prognosis in breast cancer patients. Int. J. Cancer 100: 452-455. http://dx.doi.org/10.1002/ijc.10500 PMid:12115529   Zach O, Kasparu H, Krieger O, Hehenwarter W, et al. (1999). Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol. 17: 2015-2019. PMid:10561252   Zhang M (2004). Multiple functions of maspin in tumor progression and mouse development. Front. Biosci. 9: 2218-2226. http://dx.doi.org/10.2741/1392 PMid:15353283   Zou Z, Anisowicz A, Hendrix MJ, Thor A, et al. (1994). Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529. http://dx.doi.org/10.1126/science.8290962 PMid:8290962